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Abstract
Background Data regarding long-term outcomes following surgery for cauda equina syndrome (CES) is scarce. In addition, these
studies rely on patient descriptions of the presence or absence of symptoms, with no gradation of severity. This study aimed to
assess long-term bladder, bowel, sexual and physical function using validated questionnaires in a CES cohort.
Methods A pre-existing ethically approved database was used to identify patients who had undergone surgery for CES between
August 2013 and November 2014. Patients were contacted over a 1-month period between August and September 2017 and
completed validated questionnaires via telephone, assessing bladder (Urinary Symptom Profile), bowel (Neurogenic Bowel
Dysfunction Score), sexual dysfunction (Arizona Sexual Experiences Scale) and physical function (Physical Component
Summary of SF-12 Questionnaire), with scores compared between those presenting with incomplete CES (CES-I) and CES
with retention (CES-R). Patients were also asked which of their symptoms currently they would most value treatment for and
what healthcare services they had accessed post-operatively.
Results Forty-six of 77 patients (response rate 72%, inclusion rate 60%) with a mean age of 45 years (21–83) and mean time since
admission of 43 months (range 36–60) took part in the follow-up study. The prevalence of bladder dysfunction was 76%, bowel
dysfunction 13%, sexual dysfunction 39% and physical dysfunction 48%. Patients presenting with CES-R had significantly worse
long-term outcomes in bladder (stream domain), bowel and sexual function in compared to those with CES-I. Pain was chosen as the
symptom patients would most value treatment for by 57%, but only 7% reported post-operative pain management referral.
Conclusions With a mean follow-up time of 43 months, these findings confirm the high prevalence of long-term bladder, sexual
and physical dysfunction in CES patients and that a diagnosis of CES-R confers poorer outcomes. This study provides useful,
objective data to guide the expectations of patients and clinicians.
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Abbreviations
CES Cauda equina syndrome
USP Urinary Symptoms Profile
NBDS Neurogenic Bowel Dysfunction Score
ASEX Arizona Sexual Experiences Questionnaire
SF-12 Short-Form 12 Questionnaire
PCS Physical Component Summary
Introduction
Cauda equina syndrome (CES) is a neurosurgical and spinal
orthopaedic emergency with potentially significant clinical
and medicolegal consequences for both the patient and the
medical team managing the condition. It is a relatively rare
occurrence with an incidence of 0.3–1/100,000 in the general
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population and accounts for 2–6% of lumbar spine procedures
[6]. However, it is difficult to establish the true incidence of
the condition due to a lack of consensus on an exact definition
of the syndrome and its sub-classes [5].
CES involves compression of the nerves of the cauda
equina, most commonly caused by the herniation of an inter-
vertebral disc [5]. This results in a constellation of symptoms
related to a loss of cauda equina neural function including
bladder, bowel and/or sexual dysfunction along with loss of
saddle sensation, motor control or reflexes of the lower limbs
[5]. The aim of surgical management is to restore normality of
function by urgent decompression of the cauda equina nerve
roots, but there is a risk that recovery may be only partial or
absent entirely. It is these debilitating residual symptoms that
contribute to the serious physical and socioeconomic conse-
quences that can arise following CES.
Themain body of research intoCEShas attempted to elucidate
factors affecting post-operative outcomes, such as presentation
characteristics and time to decompression [4, 7, 10, 13, 20].
Individual studies are largely equivocal, but meta-analyses con-
clude that earlier surgical decompression is beneficial for the pa-
tient, and that patients with urinary retention and overflow incon-
tinence have poorer outcomes than thosewithout [1, 3]. However,
because the main area of investigation is prognostic factors prior
to surgery, outcomes following surgery are understudied.
The few studies that do assess outcomes generally focus on
mobility, pain or bladder function, with bowel or sexual func-
tion rarely investigated, possibly due to poor assessment and
documentation [19]. Furthermore, they tend to be short term in
design, with data collection limited to the first routine follow-
up appointment, leading to a paucity of data regarding the
long-term outcomes following CES surgery. For example,
Srikandajarah et al. assess bladder outcome but only at around
3 months, with Korse et al. Investigating bladder, bowel and
sexual function but only at 6 weeks [11, 23]. This is a short
time into the patients’ recovery journey and it means that
currently both clinicians and patients have little data on which
to base long-term recovery expectations.
When long-term bladder function, bowel function and sexual
function are measured, such as in Korse et al., studies rely on
patient-reported data, with outcomes often not defined or mea-
sured using validated assessment tools [12, 24]. This
dichotomises symptoms into functional or dysfunctional with
no gradation of severity and it means that the datamay not reflect
the diverse range of residual symptoms which may be present.
Aims
This study used validated questionnaires to objectively assess a
range of long-term outcomes following CES surgery. The prima-
ry aim was to assess the patients’ current bladder, bowel and
sexual function. Secondary aims assessed quality of life related
to physical function, ability to return to work, what symptom
patients would most value treatment for currently and long-
term healthcare service use as reported by the patient.
Materials and methods
Participants and procedures
Seventy-seven patients who had attended the regional neurosur-
gical centre of the Western General Hospital, Edinburgh, be-
tween August 2013 and November 2014, were identified from
a pre-existing ethically approved database of patients with
suspected CES. This selected cohort had confirmed CES and
relevant emergency treatment. After University of Edinburgh
ethical review, the participants were contacted via telephone,
gave informed consent and completed the questionnaire deliv-
ered by the author (JEH). Patients included were those with CES
caused by degenerative disc disease; exclusion criteria comprised
CES secondary to intradural or extradural tumours, inability to
complete the questionnaire due to death, insufficient English or
untraceable contact details (Fig. 1).
Following completion of the questionnaires, electronic re-
cords were used to confirm age and gender, and to assess
whether the patient had incomplete CES (CES-I), with altered
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urinary sensation or loss of desire to void; or CES with reten-
tion (CES-R), with painless urinary retention and overflow
incontinence [7].
Questionnaire
The questionnaire contained two sections: validated and
unvalidated. In the validated section, bladder dysfunction
was assessed using the Urinary Symptom Profile (USP) with
dysfunction defined by a score ≥ 1. This allows the breakdown
of urinary symptoms into 3 domains of stress incontinence,
overactive bladder (OAB) and low stream. Increasing scores
indicate worsening dysfunction [8]. Bowel dysfunction was
assessed using the Neurogenic Bowel Dysfunction (NBD)
Score, which categorises bowel dysfunction into ‘very minor’
(score 0–6), ‘minor’ (7–9), ‘moderate’ (10–13) and ‘severe’
(14+), and rates overall bowel satisfaction out of 10 [14].
Sexual dysfunction was assessed using the Arizona Sexual
Experiences (ASEX) Scale, where dysfunction is described
by an overall score of ≥ 19, one domain ≥ 5 or 3 domains ≥
4 [16]. Lastly, physical functioning was assessed using the
Physical Component Summary (PCS) of the Short-Form 12
(SF-12) questionnaire with scores compared to the Scottish
adult average data [26].
The unvalidated section was a semi-structured interview
conducted by JEH. This assessed occupation status prior to
CES; return to work following surgery; current status includ-
ing any residual weakness/numbness/pain; whether pain pre-
vents them from doing daily activities; use of any mobility
aids; which of their symptoms they would most value relief
from, and healthcare service use.
Statistical analysis
Statistical analysis was performed using SPSS version 22 for
Mac OSX (SPSS Inc., Chicago, IL). Independent T tests were
used to analyse mean differences between the CES-I and CES-
R, with statistical significance determined by a p value < 0.05.
Results
Overall, 46/77 participants completed the study, generating a
response rate of 72% and an inclusion rate of 60% (Fig. 1).
The group comprised of 19 males and 27 females with a mean
age of 45.4 years (range 21–83) and mean time since admis-
sion of 43.4 months (range 36–50). In total, 83% (n = 38) of
participants had (CES-I) and 17% (n = 8) had CES-R. This
proportion is similar to that of the initial cohort of 74 patients,
with 81% CES-I and is therefore representative.
Bladder function
On follow-up, 76% (n = 35) of patients suffered bladder dys-
function as defined by the USP (Table 1). Overactive bladder
was the most frequently described symptom (72%), with
stress incontinence (39%) and low stream (41%) affected at
similar rates. The mean total USP score for all participants was
7.15 (± 7.17), with breakdown mean scores of overactive
bladder 4.37 (± 4.72), low stream 1.59 (± 2.70) and stress
incontinence 1.20 (± 2.07). Patients with CES-R demonstrated
significantly more dysfunctional low stream scores (+ 2.77,
p = 0.007), with no significant differences in the other USP
domains.
Bowel function
On follow-up, 13% (n = 6) of participants reported bowel dys-
function with a severity of ‘minor’ or greater as defined by the
NBDS. The mean score for satisfaction was 7.7/10, the medi-
an 9/10 and the mode 10/10. Bowel function was significantly
worse in patients with CES-R, with a mean difference of +
4.13 compared to those with CES-I (p = 0.012).
Sexual function
At follow-up 39% (n = 18) of patients reported sexual dys-
function as defined by the ASEX questionnaire. Patients were
most commonly dysfunctional in the domains of sex drive
(35% n = 16), ease (37% n = 17) and maintenance (35% n =
16) of arousal and ease of orgasm (39% n = 18) with orgasm
Table 1 Patient characteristics at follow-up
Measure n = % Mean score (±SD)
Urinary Symptoms Profile
Overall Urinary Dysfunction Score 35 76 7.15 (± 7.17)
Stress incontinence 18 39 1.20 (± 2.07)
Overactive bladder 33 72 4.37 (± 4.72)
Low stream 19 41 1.59 (± 2.70)
Neurogenic Bowel Dysfunction Score
Very minor 40 87
Minor 4 9
Moderate 0 0
Severe 2 4
Arizona Sexual Experiences Questionnaire
Sexual dysfunction 18 39
Physical function
Working 29 63
Working in a reduced capacity 6 13
Not working 6 13
Retired 5 11
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satisfaction less affected (23% n = 11). Patients with CES-R
had significantly worse sexual function, with a mean differ-
ence of + 6.76 (p = 0.009).
Physical function and employment
The SF-12 demonstrated 48% (n = 22) of patients to have
statistically significant poorer physical function than the
Scottish adult average of 49 (±10.3) and the group mean
PCS score of 39.2 (±11.3) to be markedly lower than this
too (Fig. 2). Prior to admission 74% (n = 34) patients were
in employment, with 15% (n = 7) unemployed and 11% (n =
5) retired. At follow-up, 71% (n = 29) of those of a working
age were able to return to full employment, with 15% (n = 6)
returning in a reduced capacity and 15% (n = 6) unable to
work. The number of retired patients remained n = 5. There
was no significant difference between CES-I and CES-R in
PCS scores.
Semi-structured interview
Residual symptoms were present in many with 70% (n = 32)
reporting areas of sensory loss and 44% (n = 20) reporting
current leg weakness, including 13% (n = 6) requiring walk-
ing aids to mobilise. Additionally, 70% (n = 32) of patients
described themselves as suffering pain, of which the majority
was back pain (35%, n = 16). This pain represents a significant
barrier in 57% (n = 26) who state that pain prevents them from
doing things in their daily lives.
Despite a variety of residual symptoms, the majority of
patients chose pain as the symptom that they would most
value treatment for (57% n = 26). Back pain was highlighted
as more important than leg pain with 35% (n = 16) stating it to
be the symptom that they would most like to remove (Fig. 3).
Review after discharge
Following hospital discharge, 85% (n = 39) of patients report-
ed having contact with the healthcare service, the most com-
mon being community-based physiotherapy (76% n = 35).
Fewer patients, 20% (n = 9), stated they had been referred to
specialist urology services and fewer still 7% (n = 3) had been
referred to the pain management team (Fig. 4).
Discussion
This study aimed to assess the long-term outcomes following
CES surgery by using validated questionnaires to quantify the
symptoms currently experienced by a cohort of previous CES
patients. Results demonstrated bladder, bowel and sexual dys-
function to be common problems within this population.
Physical function was also shown to be significantly reduced
in a large proportion of the patients, with many reporting per-
sistent pain, sensory loss or weakness. Patients who had CES-
R had significantly more stream-related bladder dysfunction,
bowel dysfunction and sexual dysfunction, but no difference
in physical functioning. Service use was assessed through
semi-structured interview, with the majority of patients
obtaining post-discharge physiotherapy, but few accessing
urology or pain management services.
The main limitation of this study is the relatively small
sample size (n = 46) and the risk of selection bias and social
desirability bias when sourcing data from voluntarily
responding patients. However, we achieved a follow-up rate
of 71% using telephone interviews and attempted to minimise
social desirability bias through a semi-structured interview
approach. We feel our sample size to be satisfactory, since
the median number of participants in CES studies is n = 14,
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and consider our inclusion rate to be adequate given the per-
sonal and intrusive nature of the questionnaires [24]. Whilst
the USP is useful for determining the number of patients af-
fected by bladder symptoms and in what way, it does not
provide a scale to assess the impact of the symptoms on qual-
ity of life. As such, future studies could assess this through
combining the USP with the recently validated SF-Qualiveen
[12, 21]. Use of services post-discharge was patient reported.
This was impossible to confirm due to patients coming from
many regions with differing online record systems which may
have impacted on the figures. However, urological and pain
management interventions are often quite invasive or time
intensive and the high rates of reported physiotherapy usage
gives us confidence that these figures are unlikely to be gross-
ly underestimated.
In highlighting the large burden of disease present in this
patient population, our results broadly agree with previous
literature in this area. However, the proportions of patients
with residual symptoms differ in some categories.
Our study noted a much higher rate of bladder dysfunction
(76%) than previous investigations, with McCarthy et al. find-
ing 43% of patients to have bladder dysfunction at 5 years and
Korse reporting 47% reducing to 41% on long-term follow-up
[12, 15].We hypothesise that this difference may be explained
by the use of the objective USP score which is known to have
a high sensitivity to a range of urological symptoms and
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patients would often report a symptom-free bladder, only to
show dysfunction on the USP [27]. This conjecture is support-
ed by the findings of Hellström et al. who describe how al-
though only 41% of CES patients complained of bladder dys-
function, urodynamic findings were abnormal in 76% [9].
This potentially demonstrates an opportunity to improve
symptoms in patients who are not aware of the possibility.
The majority of bladder dysfunction was in the overactive
bladder domain (72%), with less dysfunction related to stress
incontinence or low stream. This is likely due to the neural
damage sustained in CES that would preferentially affect
detrusor innervation and function over pelvic floor strength
or urethral patency [2].
Bowel dysfunction is the symptom with the greatest varia-
tion of reported prevalence in the literature and the results
from this study continued this trend, describing a much lower
rate than previously reported. Korse et al. describe a higher
prevalence of 47% on initial follow-up, reducing to 43% over
13 years [12]. The rates reported by McCarthy et al. were
higher still with 60% reporting ‘bowel disturbance’ as they
were by Podnar; however, this study did not use validated
questionnaires in data gathering [15, 18]. Using the neurogen-
ic bowel dysfunction score allowed us to assess the degree of
dysfunction present. Results showed that although the litera-
ture describes patients who complain of bowel disturbance
following CES, few are affected to a quality-of-life-reducing
level when investigated using validated methods. This is fur-
ther supported by the high median and mode average in ‘bow-
el satisfaction’ with a lower mean value.
In regard to sexual function, our results demonstrated a
lower prevalence of dysfunction (39%) compared to prior re-
search, again likely caused by the method of outcome mea-
surement. McCarthy et al. reported that 50% of patients had
some degree of dysfunction, with Korse et al. finding dysfunc-
tion prevalence to be 56% at 2 months, marginally improving
to 53% at 13 years [12, 15]. However, McCarthy et al. used
different questionnaires to assess outcomes in males and fe-
males including the unvalidated Female Pelvic Floor
Questionnaire. In Korse et al., the outcome was patient report-
ed, not objectively assessed, and 11/19 were coded as
‘dysaesthesia of genital region’ or ‘not specified’. Whilst this
may represent abnormal sexual function it does not necessar-
ily imply dysfunction and may lead to an inflated prevalence.
Physical function is rarely objectively assessed in CES pa-
tients, but previous research agrees that the majority of patients
score lower than the population average. McCarthy et al.
assessed physical function using the Short-Form 36 question-
naire, a longer questionnaire from which the SF-12 was adapted
and found CES patients to have significantly reduced function in
the ‘Physical’ and ‘Role Physical’ domains [15].
Patients with CES-R demonstrated significantly poorer low
stream bladder function, bowel function and sexual function
in comparison to those with CES-I. This is likely due to the
more serious nature of CES-R, which indicates compression
and damage to nerves of the lumbo-sacral plexus and therefore
more likely to result in subsequent permanent damage to the
nerves supplying bladder, bowel and sexual function.
Specifically, the low stream USP domain was worse in these
patients due to some needing to self-catheterise as a result of
loss of function due to CES. Few studies directly compare
long-term outcomes between patients with CES-I and CES-
R, with none to our knowledge assessing bladder, bowel, sex-
ual and physical function. Gleave and Mcfarlane feel those
with CES-R often have worse outcomes and this is supported
by Kennedy et al. note that all 5 patients in a 19 patient study
who had residual impairments at 2-year follow-up had urinary
retention at presentation [7, 10]. However, McCarthy et al.
found no significant differences between CES-I and CES-R
in a range of outcomes [15]. A meta-analysis was performed,
but was only able to report on urinary outcomes due to a lack
of data present for other functions. This showed that patients
with CES-R had relative risk of 2.58 of having bladder dys-
function compared to those with CES-I, although this result
was not significant (95%CI 0.59–11.31) [3].
In a holistic approach, we also assessed function through the
patients’ occupation status, symptom they would most value
treatment for, and NHS service use post-discharge. In patients
of working age, we found 71% were able to return to full em-
ployment, roughly matching the data from previous studies re-
garding spinal surgery which found 67% patients were able to
return to work over a 3-month to 5-year follow-up [25].
Overall, 70% of patients declared that they suffered pain on
follow-up, with 57% (n = 26) stating that it stops them from
doing things in their daily lives. Furthermore, when asked to
decide which symptom they would most value treatment for,
the most commonly chosen option was pain, with back pain
more important than leg pain. This is a considerably higher
rate of pain than would be expected, given that the proportion
of patients reporting leg or back pain 2 or more years after
discectomy for radiculopathy is 17% [17]. Little literature has
assessed the prevalence of pain as a long-term outcome, pre-
ferring to focus on other functions. However, a small study of
14 CES patients by Shapiro found that 28% suffered from
chronic pain at 6-–60 month follow-up [22].
The patient-selected most important symptoms did not cor-
relate with the patients’ stated use of NHS services. Despite
57% of this population describing their lives to be limited by
pain and it being their chosen symptom for treatment, only 7%
(n = 3) reported contact with the pain management team post-
discharge suggesting that greater utilisation of this service
could benefit this population.
Future studies should continue to follow this cohort and
reassess for any future improvement in bladder, bowel, sexual
or physical function using the questionnaires utilised by this
study. Additional work could further investigate pain as an
outcome in this population, using validated questionnaires.
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Conclusion
This long-term outcomes investigation of CES patients after
surgery has identified continued abnormal bladder, bowel, sex-
ual and physical dysfunction at a mean follow-up of 43 months.
Almost three quarters of patients continued to have bladder
symptoms at long-term follow-up and almost 40% had sexual
dysfunction. Bowel dysfunction was found to have less of an
impact than previously suspected and physical dysfunction af-
fected almost half of this cohort. Patients presenting with CES-R
had significantly worse long-term outcomes in low stream blad-
der, bowel and sexual function in compared to those with CES-I.
Pain was identified as the symptom patients would most
value treatment for, however, referrals for pain management
did not correlate with the importance given to this symptom,
highlighting the necessity of global assessment and manage-
ment in this complex patient group.
We believe this to be the largest cohort of patients with CES
investigated for long-term outcomes using validated question-
naires, and we hope this will provide some much needed data
to guide the expectations of clinicians and patients throughout
their CES diagnosis, operation and recovery process.
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